Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galecto Inc
GLTOCurrent price
4.05 USD
+0.065 USD (+1.63%)
Last closed
3.97 USD
Company
galecto.com
ISIN
US36322Q1076
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
6 828 593 USD
Yield for 12 month
-80.19 %
1Y
3Y
5Y
10Y
15Y
GLTO
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark. Address: Ole Maaloes Vej 3, Copenhagen, Denmark, 2200
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-830 000 USD
Last Year
-490 000 USD
Current Quarter
-60 000 USD
Last Quarter
-77 000 USD
Key Figures GLTO
1 year
3 years
5 years
10 years
EBITDA
-20 102 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-34.29 %
PEG Ratio
–
Return On Equity TTM
-72.61 %
Wall Street Target Price
10.00 USD
Revenue TTM
–
Book Value
16.70 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-19.11 USD
Diluted Eps TTM
-19.11 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GLTO
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History GLTO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
30.08.2024
Stock Valuation GLTO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.46
Price Book MRQ
0.33
Financials GLTO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GLTO
For 52 weeks
4.85 USD
23.50 USD
50 Day MA
6.60 USD
Shares Short Prior Month
9 470
200 Day MA
12.97 USD
Short Ratio
1.08
Shares Short
20 197
Short Percent
1.59 %
BeatStart